Clinical trial Recruiting at 1 site Interventional Ages 18 to 65

Neurofeedback treatment for light sensitivity in veterans with mild brain injuries

Official title: A Novel Neurofeedback Intervention for Photosensitivity in Mild Traumatic Brain Injury

Run by VA Office of Research and Development · NCT06109909 · Data updated 2026-11-12

This study is trying a new neurofeedback treatment to see if it can help veterans with mild brain injuries who are sensitive to light feel better.

More Mild Traumatic Brain Injury trials

Quick facts

Study typeInterventional
Ages18 Years to 65 Years
SexAll
Enrollment36 (estimated)
SponsorVA Office of Research and Development
Federal
Locations1 site (Boston, Massachusetts)
StatusRecruiting
StartedJanuary 1, 2024
Main results expectedNovember 30, 2026
Study endsNovember 30, 2026
Registry record updatedDecember 16, 2025
Trial IDNCT06109909 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates for this study are veterans aged 18-65 with a documented history of mild traumatic brain injury and symptoms of photosensitivity.

Probably not a fit

Patients with significant ocular conditions, neurodegenerative diseases, or those who cannot provide informed consent may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This pilot study aims to evaluate the feasibility and acceptability of a low-intensity pulse-based transcranial stimulation (LIP-tES) neurofeedback intervention to alleviate photosensitivity symptoms in veterans who have experienced mild traumatic brain injury (mTBI). Participants will undergo LIP-tES treatment while also receiving resting-state MRI scans to identify neurophysiological markers related to their photosensitivity. The study seeks to address the limitations of current treatments and explore the neurobiological underpinnings of photosensitivity in this population. By focusing on veterans, the study aims to provide insights into effective, non-invasive treatment options for a common and debilitating condition following mTBI.

Why it matters

Potential benefit: If successful, this intervention could significantly reduce photosensitivity symptoms, improving the quality of life for veterans with mild traumatic brain injuries.

How similar studies have gone: While there is preliminary evidence suggesting neurofeedback may help with post-concussive symptoms, this specific approach using LIP-tES for photosensitivity is novel and has not been extensively tested.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Ages 18-65
* Documented history of mTBI at least 6 months prior to initial study visit
* Documented symptoms of photosensitivity
* Eye exam within the last 12 months documenting best-corrected acuity of 20/20 or better, normal pupillary function, color vision, no abnormalities on OCT scan, and normal Humphrey Visual Field test

Exclusion Criteria:

* History of strabismus or amblyopia
* Significant ocular media opacity that could reduce the amount of light entering the pupil in one or both eyes
* Previous or current history of retinal or optic nerve pathology in one or both eyes
* History of stroke and/or visual neglect
* History of neurodegenerative disease (e.g., Parkinson's, multiple sclerosis)
* History of epilepsy or seizures
* History of motor tics
* Current use of medications or substances that may severely affect pupillary response and/or increase photosensitivity
* Individuals with impaired decision-making capacity
* Illiterate or no English language proficiency

Where it's running

  • VA Boston Healthcare System Jamaica Plain Campus, Jamaica Plain, MA
    Boston, Massachusetts, United States
    Recruiting

Study contacts

  • Principal investigator: Francesca C Fortenbaugh, PhD — VA Boston Healthcare System Jamaica Plain Campus, Jamaica Plain, MA
  • Study coordinator: Francesca C Fortenbaugh, PhD
  • Email: Francesca.Fortenbaugh@va.gov
  • Phone: (857) 364-4362

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.